openPR Logo
Press release

Breast Biopsy Device Market worth $2,037.69 million by 2030, growing at a CAGR of 10.72% - Exclusive Report by 360iResearch

07-04-2024 03:00 PM CET | Health & Medicine

Press release from: 360iResearch

Breast Biopsy Device Market | 360iResearch

Breast Biopsy Device Market | 360iResearch

The "Breast Biopsy Device Market by Product (Biopsy Needles, Biopsy Tables, Guidance Systems), Test (Needle Breast Biopsy, Surgical Biopsy), Guidance, End-Use - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/breast-biopsy-device?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Breast biopsy devices, comprising needle biopsy systems, core needle biopsy, fine needle aspiration, and vacuum-assisted biopsy systems, are essential diagnostic tools for detecting breast tissue abnormalities such as lumps or calcifications, determining whether they are benign or malignant. The rising incidence of breast cancer and increased public awareness highlight the necessity of accurate and early diagnosis, thereby driving demand for these devices in clinical and hospital settings. Cancer research support, advancements in minimally invasive techniques, and heightened public awareness further augment market growth. Hospitals, diagnostic centers, and ambulatory surgical centers (ASCs) are significant end-users. Opportunities for market growth include integrating artificial intelligence in biopsy procedures, expanding into emerging markets with improving healthcare infrastructures, and developing customizable biopsy devices for specific demographics. Industry recommendations emphasize increased investment in research and development (R&D) for user-friendly devices, strengthening distribution networks to reach broader customer bases, and partnering with research institutions and healthcare providers for technological advancements. However, challenges such as high procedure costs, technical complexity requiring specialized training, and stringent regulatory standards can impede market growth. Ongoing innovation and research are focused on non-invasive techniques, development of portable and easy-to-use devices, and the use of biocompatible materials to enhance device safety and patient comfort. The market's rapid technological advancements and push for minimally invasive procedures suggest a dynamic and competitive landscape, requiring businesses to stay abreast of emerging trends and customer preferences to maintain a competitive edge. Overall, the breast biopsy device market shows substantial growth potential driven by rising cancer awareness, technological innovations, and supportive government initiatives, although addressing inherent challenges remains crucial for achieving sustainable growth and market leadership.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/breast-biopsy-device?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

Market Segmentation & Coverage:

This research report categorizes the Breast Biopsy Device Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Biopsy Needles, Biopsy Tables, Guidance Systems, and Localization Wires.

Based on Test, market is studied across Needle Breast Biopsy and Surgical Biopsy. The Needle Breast Biopsy is further studied across Core-Needle Aspiration, Fine-Needle Aspiration, and Vacuum-Assisted Core Biopsy. The Surgical Biopsy is further studied across Excisional Breast Biopsy and Incisional Breast Biopsy.

Based on Guidance, market is studied across Magnetic Resonance-Guided, Mammography-Guided Stereotactic, and Ultrasound-Guided.

Based on End-Use, market is studied across Diagnostic Centers and Hospitals & Clinics.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Company Profiles:

The report delves into recent significant developments in the Breast Biopsy Device Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Argon Medical Devices, Inc., Becton, Dickinson and Company, Cook Group Incorporated, Danaher Corporation, FUJIFILM Corporation, GE HealthCare Technologies Inc., Halma plc, Hologic, Inc, INRAD Inc., Medline Industries, LP, Medtronic PLC, Merit Medical Systems, Inc., Ningbo Xinwell Medical Technology Co., LTD., PAJUNK GmbH, Planmeca Oy, Point Blank Medical, Siemens Healthcare GmbH, SNVL Varay Laborix, STERYLAB S.r.l., Suretech Medical Inc., Thermo Fisher Scientific Inc., Trivitron Healthcare, Vector Medical, Inc., and Zamar Care.

Introducing ThinkMi Query: Revolutionizing Market Intelligence with AI-Powered Insights for the Breast Biopsy Device Market

We proudly unveil ThinkMi Query, a cutting-edge AI product designed to transform how businesses interact with the Breast Biopsy Device Market. ThinkMi Query stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi Query is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it's a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Breast Biopsy Device Market. Embrace the future of market analysis with ThinkMi Query, where informed decisions lead to remarkable growth.

Ask Question to ThinkMi Query @ https://www.360iresearch.com/library/intelligence/breast-biopsy-device?utm_source=openpr&utm_medium=referral&utm_campaign=query

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Breast Biopsy Device Market, by Product
7. Breast Biopsy Device Market, by Test
8. Breast Biopsy Device Market, by Guidance
9. Breast Biopsy Device Market, by End-Use
10. Americas Breast Biopsy Device Market
11. Asia-Pacific Breast Biopsy Device Market
12. Europe, Middle East & Africa Breast Biopsy Device Market
13. Competitive Landscape
14. Competitive Portfolio

Read More @ https://www.360iresearch.com/library/intelligence/breast-biopsy-device?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Breast Biopsy Device Market worth $2,037.69 million by 2030, growing at a CAGR of 10.72% - Exclusive Report by 360iResearch here

News-ID: 3566381 • Views:

More Releases from 360iResearch

Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Global Treatment Demand
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and expected to reach USD 10.06 billion in 2024, at a CAGR 7.63% to reach USD 15.71 billion by 2030.
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 2023 and expected to reach USD 292.84 billion in 2024, at a CAGR 11.08% to reach USD 552.63 billion by 2030.
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 and expected to reach USD 62.23 billion in 2024, at a CAGR 9.99% to reach USD 110.34 billion by 2030.
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital

All 5 Releases


More Releases for Biopsy

Liquid Biopsy Market - Unlocking Insights in Liquid: Transforming the Biopsy Lan …
Newark, New Castle, USA: The "Liquid Biopsy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Liquid Biopsy Market: https://www.growthplusreports.com/report/liquid-biopsy-market/8430 This latest report researches the industry structure, sales, revenue,
Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to …
Download Free PDF Sample Papers Now at Biopsy Devices Market https://www.reportsnreports.com/contacts/requestsample.aspx?name=1159148 . Biopsy devices market report analyzes various types of biopsy devices in market and their adoption patterns. It aims at estimating market size and future growth potential of biopsy devices market for different segments such as product, guidance technique, application, end user, and region. Global biopsy devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East
Biopsy Device Market to Increase to US$ 2,621 Mn by 2026 | Guidance System (Ster …
Key players focussing on strategic M&A for amplified market shares Patients are increasingly preferring minimally invasive surgical procedures in order to avoid conventional surgical complications and side-effects, promoting sales of biopsy devices, leading to the growth of the biopsy devices globally. In addition to enabling the accurate diagnosis, a biopsy device assures minimal patient discomfort and trauma. This is identified to be a major factor impacting the popularity of biopsy, and
Breast Biopsy Market Report 2018: Segmentation by Product (Vacuum Assisted Biops …
Global Breast Biopsy market research report provides company profile for Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume,
Biopsy Devices Market Report 2018: Segmentation by Product (Core Needle Biopsy, …
Global Biopsy Devices market research report provides company profile for C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Bone Biopsy Market 2018 | Needle Biopsy | Open Biopsy | Bone Cancer | Bone Infec …
The Global Bone Biopsy Market is growing continuously and expected to grow at a CAGR of 5.7% from 2017 to 2023. Bone biopsy is performed to diagnose various bone disorders such as bone cancer, bone infection, osteoporosis and chronic kidney disease. Nowadays, biopsy procedure has received great importance in oncology as one of the promising methods in cancer diagnostics. The demand for needle biopsy is found to be increasing from